BamSEC and AlphaSense Join Forces
Learn More

Elanco Animal Health Incorporated – Indentures

NYSE: ELAN    
Share price (6/4/26): $24.71    
Market cap (6/4/26): $12.3 billion

Indentures Filter

EX-4.5
from 10-K 1 page Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.5
from 10-K 2 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from 10-K 34 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from 8-K 46 pages Elanco Animal Health Incorporated, as Issuer, and Deutsche Bank Trust Company Americas, as Trustee Second Supplemental Indenture Dated as of January 27, 2020 to Indenture Dated as of August 28, 2018 2.75% Senior Amortizing Notes Due 2023
12/34/56
EX-4.1
from 8-K 113 pages Purchase Contract Agreement Dated as of January 27, 2020 Between Elanco Animal Health Incorporated and Deutsche Bank Trust Company Americas, as Purchase Contract Agent, as Attorney-In-Fact for the Holders of Equity-Linked Securities From Time to Time as Provided Herein and as Trustee Under the Indenture Referred to Herein
12/34/56
EX-4.3
from S-3ASR 10 pages Annex 27 Liquidation of Consideration Shares
12/34/56
EX-4.4
from S-8 12 pages Elanco Animal Health Incorporated Directors’ Deferral Plan Effective September 18, 2018
12/34/56
EX-4.3
from S-8 27 pages Form of 2018 Elanco Stock Plan
12/34/56
EX-4.2
from S-8 23 pages Elanco Animal Health Incorporated Amended and Restated Bylaws Adopted as of September 5, 2018 (Effective September 19, 2018) Elanco Animal Health Incorporated Amended and Restated Bylaws Index
12/34/56
EX-4.1
from S-8 10 pages Elanco Animal Health Incorporated (An Indiana Corporation) Amended and Restated Articles of Incorporation
12/34/56
EX-4.4
from S-1/A 15 pages Exchange and Registration Rights Agreement
12/34/56
EX-4.3
from S-1/A 67 pages Elanco Animal Health Incorporated First Supplemental Indenture Dated as of August 28, 2018 3.912% Senior Notes Due 2021 4.272% Senior Notes Due 2023 4.900% Senior Notes Due 2028 (First Supplemental Indenture to the Indenture Dated as of August 28, 2018) Deutsche Bank Trust Company Americas, as Trustee First Supplemental Indenture
12/34/56
EX-4.2
from S-1/A 57 pages Elanco Animal Health Incorporated, as Issuer, and Deutsche Bank Trust Company Americas, as Trustee Indenture Dated as of August 28, 2018
12/34/56
EX-4.1
from S-1/A 1 page Form of Certificate of Common Stock
12/34/56